Skip to content

Exploration of Pregnant Women's Reluctance Toward COVID-19 Vaccination

Exploration of Pregnant Women's Reluctance Toward COVID-19 Vaccination

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06968117
Enrollment
15
Registered
2025-05-13
Start date
2021-11-01
Completion date
2023-01-01
Last updated
2025-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reluctance Pregnant Women's, Vaccinate Against Covid-19

Brief summary

This study aims to explore the reasons behind the reluctance of pregnant women to get vaccinated against COVID-19. With the ongoing pandemic, it has become essential to understand the concerns that women have regarding the COVID-19 vaccine, especially during pregnancy. Pregnant women are at a higher risk of severe complications from COVID-19, including premature birth, preeclampsia, and the need for intensive care.The goal of this research is to identify the barriers that prevent pregnant women from getting vaccinated, whether they are based on fears, misconceptions, or a lack of information. By understanding these concerns, healthcare providers can have better conversations with their patients and provide accurate, evidence-based information to help them make informed decisions about their health and the health of their unborn child.Through interviews and visual methods, the study seeks to gather valuable insights into the emotional and psychological aspects of vaccine hesitancy among pregnant women. These findings will help develop a tool to assist healthcare providers in addressing vaccine hesitancy effectively, ensuring that women are given all the necessary information to make the best decision for their health and the well-being of their baby.

Interventions

None listed

Sponsors

Centre Hospitalier de Gonesse
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum

Inclusion criteria

* During pregnancy follow-up consultations, * Following their visit to the Gynecology-Obstetrics emergency department, regardless of the reason, * Hospitalized in the diabetology department or in the high-risk pregnancy (HRP) or postpartum care department.

Exclusion criteria

* The patient is over 18 years old

Design outcomes

Primary

MeasureTime frame
The rate of vaccine hesitancy among pregnant women, assessed through a standardized questionnaire.January 2021-April 2023

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026